admin – Page 4658 – Get News Story

Vdocipher Unveils Tips for Finding the Perfect Subscription Video on Demand Service

Subscription Video on Demand (SVOD) services have transformed how audiences consume entertainment, offering a vast library of movies, TV shows, and exclusive content at their fingertips. With an ever-growing number of options, selecting the right SVOD service can be overwhelming. This guide will help you evaluate your preferences and make an informed decision when choosing an SVOD service.

Key Factors to Consider When Choosing an SVOD Service

1. Content Library

The primary factor in selecting an SVOD platform is its content offering. Consider:

Genre Variety: Does the service provide content that aligns with your interests, such as drama, action, documentaries, or anime?

Exclusive Content: Look for platforms that offer original shows and movies you won’t find elsewhere.

Regional Content: If you’re interested in local language films or series, ensure the service supports regional programming.

2. Device Compatibility

Your chosen SVOD service should work seamlessly across your devices. Most platforms support:

Smartphones (iOS and Android)

Smart TVs (various brands)

Streaming devices (Roku, Fire Stick, Chromecast)

Laptops and desktops

Ensure the platform has an intuitive interface across all your devices.

3. Streaming Quality

Evaluate the video and audio quality provided by the service:

Resolution: Video streaming platforms like Netflix and Disney+ offer 4K UHD streaming for premium subscribers.

Adaptive Streaming: This ensures seamless playback, even on slower internet connections.

Audio Standards: Look for services with Dolby Atmos or surround sound for a cinematic experience.

4. Pricing and Plans

Compare subscription costs and tiers:

Some services offer basic plans with SD video quality, while premium plans include HD and UHD content.

Assess family plans that allow multiple profiles and simultaneous streams.

Explore free trials or discounted bundles (e.g., Hulu and Disney+ packages).

5. Ad-Free Experience

If you prefer uninterrupted viewing, opt for services that provide ad-free plans. Many SVOD platforms, such as Netflix and Apple TV+, have completely ad-free tiers, while others like Hulu offer both ad-supported and ad-free options.

Popular SVOD Services to Consider

1. Netflix

Strengths: Global availability, vast library, high-quality originals like Stranger Things and The Crown.

Unique Features: Multiple user profiles, parental controls, and downloadable content.

Pricing: Multiple tiers from basic to premium (with 4K UHD).

2. Amazon Prime Video

Strengths: Large selection of movies, TV shows, and Amazon Originals like The Marvelous Mrs. Maisel.

Unique Features: Integration with Amazon shopping, add-ons for other channels like HBO and Showtime.

Pricing: Included with Amazon Prime membership.

3. Disney+

Strengths: Exclusive rights to Marvel, Star Wars, Pixar, and Disney classics.

Unique Features: Family-friendly programming and group watch features.

Pricing: Affordable standalone plans or bundles with Hulu and ESPN+.

4. Hulu

Strengths: Up-to-date TV shows, Hulu Originals, and a mix of movies and live TV options.

Unique Features: Flexible pricing with ad-supported and ad-free options.

Pricing: Starting at $7.99/month.

5. Apple TV+

Strengths: Focused on high-quality, original content like Ted Lasso and The Morning Show.

Unique Features: Ad-free experience and integration with Apple devices.

Pricing: $6.99/month, free for three months with new Apple device purchases.

6. HBO Max (soon to be Max)

Strengths: Award-winning shows like Game of Thrones, Succession, and Warner Bros. movie catalog.

Unique Features: Simultaneous theatrical releases and streaming.

Pricing: $15.99/month for ad-free.

7. Crunchyroll

Strengths: The go-to platform for anime enthusiasts with simulcasts and exclusive titles.

Unique Features: Access to manga and Asian dramas.

Pricing: Tiers starting at $7.99/month.

Tips for Making the Right Choice

1.Trial Periods: Most SVOD platforms offer free trials—take advantage to explore their libraries.

2.Family Needs: If multiple users will access the account, choose a service with multiple profiles and simultaneous streaming options.

3.Content Refresh Rate: Ensure the platform frequently updates its library with new content.

4.Bundled Services: Consider bundled offers that include additional services like live sports or music streaming.

Conclusion

The right SVOD service depends on your preferences, budget, and viewing habits. By evaluating content libraries, pricing, device compatibility, and features, you can select a platform that enhances your entertainment experience. Whether you’re a movie buff, a TV binge-watcher, or a family with diverse interests, there’s an SVOD service tailored to your needs.

Media Contact
Company Name: Vdocipher
Contact Person: Pooja
Email: Send Email
City: Gurugram
Country: India
Website: https://www.vdocipher.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vdocipher Unveils Tips for Finding the Perfect Subscription Video on Demand Service

VdoCipher Highlights Key Benefits of Secure Live Streaming Solutions

Live video streaming has become a powerful tool for businesses and creators to connect with their audiences in real time. Whether it’s a product launch, webinar, or online performance, live streaming platforms offer the tools to broadcast engaging content globally. With numerous options available, choosing the right platform can be overwhelming. This article highlights the 10 best live video streaming services for businesses and creators, covering features, pricing, and ideal use cases.

1. YouTube Live

Why Choose It?

YouTube Live is one of the most accessible platforms for live streaming, with its massive audience base and robust features for free broadcasts.

Key Features:

Unlimited audience reach.

Live chat for audience interaction.

Analytics to track performance.

Monetization options like Super Chats and ads.

Ideal For:

Creators and businesses looking to engage with a global audience without additional costs.

Pricing:

Free, with optional premium features for YouTube Premium members.

2. Facebook Live

Why Choose It?

With its integrated social features, Facebook Live allows businesses to reach their target audience while fostering engagement.

Key Features:

Real-time reactions and comments.

Integration with Facebook Ads for promotions.

Cross-posting to groups and pages.

Ideal For:

Small businesses and creators focusing on community engagement.

Pricing:

Free, with paid options for boosting reach through ads.

3. LinkedIn Live

Why Choose It?

LinkedIn Live is perfect for professional audiences, offering features tailored for webinars, product launches, and corporate events.

Key Features:

Audience targeting for professionals.

Customization through third-party tools like StreamYard.

Access to engagement metrics.

Ideal For:

B2B businesses, recruiters, and thought leaders.

Pricing:

Free, with premium LinkedIn features available.

4. Zoom

Why Choose It?

Zoom has become synonymous with virtual events, offering reliable live streaming options for webinars and meetings.

Key Features:

Webinar hosting for up to 10,000 attendees.

Screen sharing and breakout rooms.

Integration with social media platforms.

Ideal For:

Educational webinars, team meetings, and corporate events.

Pricing:

Starts at $14.99/month.

5. Twitch

Why Choose It?

Primarily known for gaming, Twitch also supports diverse live streaming categories, from music to podcasts.

Key Features:

Interactive chat with emotes and extensions.

Monetization options like subscriptions and donations.

Community-building tools.

Ideal For:

Gaming creators and entertainment-focused brands.

Pricing:

Free, with optional paid features for creators.

6. Vimeo Livestream

Why Choose It?

Vimeo offers a premium live streaming experience with high-quality video and robust customization tools.

Key Features:

Ad-free broadcasting.

Integration with custom video players.

Advanced analytics and audience engagement tools.

Ideal For:

Businesses looking for a polished, professional live streaming platform.

Pricing:

Starts at $65/month.

7. Instagram Live

Why Choose It?

Instagram Live is ideal for short, engaging sessions targeting younger audiences.

Key Features:

Integration with Instagram Stories for promotion.

Interactive features like Q&A and polls.

Real-time notifications for followers.

Ideal For:

Creators and brands focusing on lifestyle, fashion, and entertainment.

Pricing:

Free.

8. Restream

Why Choose It?

Restream allows you to broadcast simultaneously on multiple platforms, increasing reach and visibility.

Key Features:

Multistreaming to over 30 platforms.

Analytics dashboard for performance tracking.

Custom branding options.

Ideal For:

Businesses and creators with diverse audiences across platforms.

Pricing:

Free for basic plans; paid plans start at $16/month.

9. Microsoft Teams Live Events

Why Choose It?

Microsoft Teams is ideal for enterprise-level live events, offering secure and professional-grade streaming tools.

Key Features:

Support for up to 20,000 attendees.

Integration with Office 365 tools.

Secure content delivery with enterprise-grade compliance.

Ideal For:

Corporate events, town halls, and internal communications.

Pricing:

Included in Office 365 subscriptions.

10. OBS Studio (Open Broadcaster Software)

Why Choose It?

OBS Studio is a free, open-source platform for professional live streaming, offering powerful customization options.

Key Features:

Multistreaming support with plugins.

Real-time video/audio mixing and effects.

Integration with popular platforms like YouTube and Twitch.

Ideal For:

Tech-savvy creators and businesses requiring advanced customization.

Pricing:

Free.

Choosing the Right Platform

When selecting a live video streaming service, consider the following factors:

1.Target Audience: Platforms like LinkedIn are better for professionals, while Twitch excels in entertainment.

2.Budget: Free options like YouTube Live are great for beginners, while Vimeo caters to premium needs.

3.Features: Evaluate analytics, audience engagement tools, and streaming quality.

4.Monetization: Platforms like Twitch and YouTube offer direct revenue opportunities.

Conclusion

The live video streaming landscape offers a wealth of options, each catering to unique needs and audiences. From free platforms like Facebook Live to premium video hosting solutions like VdoCipher, there’s a service for every business and creator. By choosing the right platform, you can amplify your message, build deeper connections with your audience, and achieve your streaming goals in 2024.

Media Contact
Company Name: Vdocipher
Contact Person: Pooja
Email: Send Email
City: Gurugram
Country: India
Website: https://www.vdocipher.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: VdoCipher Highlights Key Benefits of Secure Live Streaming Solutions

Redway Power Unveils Versatile Group 24 Battery Series: 24F, 24H, 24R, and 24T for Every Application

Redway Power, a leader in innovative battery solutions, is thrilled to announce the launch of its new Group 24 battery series, which includes four distinct models: 24F, 24H, 24R, and 24T. Designed to meet the diverse needs of consumers across a wide range of applications—including recreational vehicles (RVs), marine vessels, and automobiles—these batteries offer exceptional performance and reliability.

Tailored Solutions for Every Need

Group 24 batteries are standardized units measuring approximately 10.25 x 6.75 x 8.75 inches. They are well-regarded for their versatility, making them suitable for various energy demands. The different suffixes—F, H, R, and T—indicate specific terminal configurations, enabling users to select the battery that best fits their installation requirements:

Designation	Description	Terminal Type
24F	Front terminal configuration	Top-post
24H	High-capacity variant	Standard
24R	Reverse terminal configuration	Top-post
24T	Enhanced terminal features	Varies

Outstanding Performance Characteristics

Redway Power’s Group 24 batteries are engineered for optimal performance, featuring:

Capacity: Ranging from 70 to 85 Ah, ideal for moderate energy demands.
Cold Cranking Amps (CCA): Between 600 to 750 CCA, ensuring reliable starting power even in cold conditions.
Reserve Capacity (RC): Typically between 120 to 150 minutes, providing essential power during alternator failures.

Versatile Applications

These batteries are perfect for a variety of uses:

RVs: Powering lights, appliances, and other electrical systems.
Boats: Serving as starting or deep-cycle batteries for trolling motors.
Automobiles: Ideal for vehicles requiring dependable starting power without excessive weight.

Commitment to Safety

At Redway Power, safety is a top priority. We encourage users to follow proper installation practices:

Wear protective gear (gloves and safety glasses).
Disconnect the negative terminal first.
Secure the battery in place to prevent movement.

Innovations in Battery Technology

Recent advancements in battery technology have led to improved efficiency and lifespan for Group 24 batteries, particularly with lithium-ion variants. As consumer demand for eco-friendly options increases, Redway Power remains committed to delivering high-quality solutions that align with environmental standards while ensuring optimal performance.

Expert Insights

“Group 24 batteries provide unmatched versatility and reliability across various applications,” says a Redway Power representative. “We are dedicated to offering our customers the best energy solutions tailored to their specific needs.”

Competitive Edge

Redway Power stands out among competitors by offering a comprehensive range of Group 24 batteries with unique configurations tailored for different applications. Other notable brands include Optima Batteries, Interstate Batteries, DieHard, and Exide; however, Redway’s focus on customization sets it apart in the market.In conclusion, the introduction of Redway Power’s Group 24 battery series highlights its commitment to innovation and customer satisfaction. By understanding the specifications and variations of these batteries, consumers can ensure they select the right product for their specific needs.For more information about Redway Power’s new Group 24 battery series or to explore our full range of products, please visit their website.

Media Contact
Company Name: Redway Power, Inc.
Contact Person: Mr. Smith
Email: Send Email
Phone: +86 (755) 28010506
City: Shenzhen
State: Guangdong
Country: China
Website: https://www.redwaypower.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Redway Power Unveils Versatile Group 24 Battery Series: 24F, 24H, 24R, and 24T for Every Application

“In The Light Roofing” is Gaining Popularity in Center Valley for its Industry-Leading Roof Repair

Since its launch, In The Light Roofing has emerged as one of Pennsylvania’s most trusted roofing companies. The company is proud to spotlight its specialized roof repair services for homeowners and businesses in Center Valley. From fixing leaks to replacing storm-damaged shingles, the company’s dedicated repair team ensures fast, effective, and affordable solutions for roofing emergencies and ongoing maintenance.

Roof issues like leaks, storm damage, and worn-out shingles are some of the most urgent concerns for property owners. In The Light Roofing understands how critical timely repairs are for protecting homes and businesses, which is why their team prioritizes speed, efficiency, and lasting results through its comprehensive roof repair services for Center Valley.

“Roof repairs can’t wait. Whether it’s a sudden leak or long-term wear, our team works quickly to restore roofs and prevent further damage,” said Bryson Berard, CEO of In The Light Roofing. “We’re committed to providing Center Valley homeowners with fast, reliable solutions that extend the lifespan of their roofs.”

As a reputable Center Valley roofing contractor, In The Light Roofing offers a full range of repair services to address the most common roofing issues. These include:

Leak Detection & Water Damage Repair: Addressing leaks at the source before they cause extensive structural damage or mold growth.
Storm Damage Restoration: Repairing and replacing materials after hail, wind, and storm-related damage.
Shingle Replacement & Repair: Replacing cracked, curled, or missing shingles to restore roof integrity and maintain curb appeal.
Flashing & Gutter Repairs: Repairing or replacing flashing and gutters to ensure water flows away from the home properly.

The company’s team of certified roofers works with all major roofing materials, including asphalt shingles, metal roofing, cedar shake, and slate, to ensure high-quality repairs that blend seamlessly with the existing roof design.

Some of the key reasons why Center Valley Homeowners Trust In The Light Roofing for Repairs include:

Emergency Repairs Anytime, Day or Night: Roof damage doesn’t wait for business hours. In The Light Roofing offers 24/7 emergency response to secure homes after sudden weather events or unexpected leaks.
GAF Master Elite Certification: Homeowners can have peace of mind knowing that every repair is performed by a GAF Master Elite-certified contractor—an industry distinction held by only a select number of roofing companies nationwide.
Expert Repairs for All Roof Types: Whether it’s asphalt, slate, cedar shake, or metal roofing, In The Light Roofing has the experience and expertise to handle it all.
Affordable Pricing & Free Estimates: Homeowners never have to worry about hidden fees or surprises. Customers receive clear, upfront pricing and free roof repair estimates before any work begins.
Seasonal Discounts for First-Time Customers: New customers in Center Valley can access special, limited-time discounts on their first repair service, making it even easier to get essential roof repairs done.

“Our repairs aren’t just quick fixes — they’re long-term solutions,” said Berard. “With each repair, we aim to strengthen the roof and extend its lifespan so homeowners can feel safe and secure.”

Since its founding in 2017, In The Light Roofing has grown into a community-trusted roofing provider with a strong focus on integrity, quality, and reliability. As a locally owned and operated business, the company understands the unique challenges that Center Valley weather poses for homeowners. From seasonal storms to fluctuating temperatures, roofs in the area endure constant exposure to the elements. This local knowledge allows In The Light Roofing to deliver highly effective, location-specific repairs that stand the test of time.

Homeowners in Center Valley experiencing roof issues are encouraged to schedule a free inspection with In The Light Roofing. The team will provide a detailed assessment, outline repair options, and offer transparent pricing so customers can make informed decisions.

With a focus on fast service, top-quality craftsmanship, and affordable pricing, In The Light Roofing continues to raise the standard for roof repair services in Center Valley and beyond.

For more information or to schedule your free estimate, visit the official website at https://inthelightroofing.com/service-area/center-valley-roofing-contractor/

About In The Light Roofing

In The Light Roofing is one of Pennsylvania’s leading roofing companies, offering a complete range of services, including roof repair, roof replacement, and storm damage restoration. Since 2017, the company has been committed to delivering expert craftsmanship and customer satisfaction. As a GAF Master Elite Certified contractor, In The Light Roofing provides reliable roofing solutions with a focus on integrity, transparency, and long-term value.

For updates, follow In The Light Roofing on social media:

Facebook: https://www.facebook.com/InthelightcontractingLLC/
Instagram: https://www.instagram.com/inthelightroofing/
YouTube: https://www.youtube.com/@inthelightroofing/

Find In The Light Roofing on Google Maps: https://maps.app.goo.gl/4Hg4PejCaneEYMs1A

Media Contact
Company Name: In The Light Roofing
Contact Person: Bryson Berard
Email: Send Email
City: Center Valley
State: Pennsylvania
Country: United States
Website: inthelightroofing.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: “In The Light Roofing” is Gaining Popularity in Center Valley for its Industry-Leading Roof Repair

Chronic Rhinosinusitis with Nasal Polyps Market Size was highest in the US among the 7MM is ~USD 1,674 million in 2023, is expected to grow by 2034 at a CAGR of 10.8% | DelveInsight

DelveInsight’s “Chronic Rhinosinusitis with Nasal Polyps Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Chronic Rhinosinusitis with Nasal Polyps, historical and forecasted epidemiology as well as the Chronic Rhinosinusitis with Nasal Polyps market trends in the United States, EU4, and the UK (Germany, France, Italy, Spain) and the United Kingdom, and Japan.

Discover Key Insights into the Chronic Rhinosinusitis with Nasal Polyps Market with DelveInsight’s In-Depth Report @ Chronic Rhinosinusitis with Nasal Polyps Market Size

Key Takeaways from the Chronic Rhinosinusitis with Nasal Polyps Market Report

In November 2024:- AstraZeneca- This is a multicentre, open-label, single-arm, phase IIIb study is to describe changes from baseline in (1) participant-reported nasal congestion as evaluated by the nasal congestion score (NCS) and (2) participant-reported sino-nasal symptoms as evaluated by sino-nasal outcome test, 22 item (SNOT-22) following initiation of tezepelumab treatment.
In November 2024:- Upstream Bio Inc.- The primary purpose of this study is to assess the effect of verekitug (UPB-101) on the endoscopically determined size and extend of nasal polyps in participants with chronic rhinosinusitis with nasal polyps (CRSwNP) and to assess the safety and tolerability of verekitug (UPB-101) compared to placebo.
In the assessment done by DelveInsight, the estimated total Chronic Rhinosinusitis Prevalent Cases in the 7MM were ~70,188 thousand in 2023.
The highest total Chronic Rhinosinusitis with Nasal Polyps diagnosed prevalent cases were accounted by the US in 2023 (~2,209 thousand), which is expected to show a rise in the future.
Among the European countries, Germany had the highest Chronic Rhinosinusitis with Nasal Polyps diagnosed prevalent cases with ~616 thousand cases, followed by the UK, which had diagnosed prevalent population of ~441 thousand in 2023. On the other hand, Spain had the lowest diagnosed prevalent population (~189 thousand cases).
Japan had ~202 thousand total diagnosed prevalent cases of Chronic Rhinosinusitis with Nasal Polyps in 2023, accounting for approximately 5% in 7MM.
In 2023, in the US, the gender-specific diagnosed prevalent cases of Chronic Rhinosinusitis with Nasal Polyps were highest for males (~55%), as compared to males (~45%), which is attributed to factors such as hormonal differences and physiology, lifestyle and occupational factors and others.
The leading Chronic Rhinosinusitis with Nasal Polyps Companies such as AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Genentech, Inc, Novartis, Upstream Bio Inc., Regeneron Pharma, Genrix (Shanghai) Biopharmaceutical, Guangdong Hengrui Pharmaceutical, Keymed Biosciences Co.Ltd, and others
Promising Chronic Rhinosinusitis with Nasal Polyps Therapies such as NUCALA (mepolizumab), TEZSPIRE (tezepelumab), FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Omalizumab, Xolair, Verekitug (UPB-101), Dupilumab SAR231893, GR1802 injection, SHR-1905 Injection, CM310, and others

Stay ahead in the Chronic Rhinosinusitis with Nasal Polyps Therapeutics Market with DelveInsight’s Strategic Report @ Chronic Rhinosinusitis with Nasal Polyps Market Outlook

Chronic Rhinosinusitis with Nasal Polyps Epidemiology Segmentation in the 7MM

Total Prevalence of Chronic Rhinosinusitis with Nasal Polyps
Prevalent Cases of Chronic Rhinosinusitis with Nasal Polyps by severity
Gender-specific Prevalence of Chronic Rhinosinusitis with Nasal Polyps
Diagnosed Cases of Episodic and Chronic Chronic Rhinosinusitis with Nasal Polyps

Download the report to understand which factors are driving Chronic Rhinosinusitis with Nasal Polyps epidemiology trends @ Chronic Rhinosinusitis with Nasal Polyps Prevalence

Chronic Rhinosinusitis with Nasal Polyps Marketed Drugs

NUCALA (mepolizumab): GlaxoSmithKline

GSK’s NUCALA (mepolizumab) is the first IL-5 therapy approved as an add-on treatment in the US for adults with CRSwNP to target eosinophilic inflammation in adult patients 18 years of age and older with inadequate response to nasal corticosteroids. The recommended dosage of mepolizumab is 100 mg, administered once every 4 weeks by subcutaneous injection into the upper arm, thigh, or abdomen. Mepolizumab is an IL-5 antagonist (IgG1 kappa). IL-5 is the major cytokine responsible for the growth and differentiation, recruitment, activation, and survival of eosinophils. Mepolizumab binds to IL-5 with a dissociation constant of 100 pM, inhibiting the bioactivity of IL-5 by blocking its binding to the alpha chain of the IL-5 receptor complex expressed on the eosinophil cell surface. By inhibiting IL-5 signaling, mepolizumab reduces the production and survival of eosinophils; however, the mechanism of mepolizumab action in asthma, CRSwNP, EGPA, and HES has not been definitively established.

Chronic Rhinosinusitis with Nasal Polyps Emerging Drugs

TEZSPIRE (tezepelumab): AstraZeneca/Amgen

TEZSPIRE (tezepelumab) is a potential human monoclonal antibody (immunoglobulin [Ig] G2λ) that inhibits the action of thymic stromal lymphopoietin (TSLP). TSLP expression is elevated in the airways of patients with asthma compared with healthy individuals and in nasal polyp tissue from patients with CRSwNP compared with healthy sinus tissue or patients with CRS without NP. Tezepelumab binds specifically to TSLP, preventing its interaction with its heterodimeric receptor. Tezepelumab is currently under Phase III clinical trials to evaluate the efficacy and safety of tezepelumab in adults with severe CRSwNP. This trial is based on positive results of tezepelumab from the PATHWAY and NAVIGATOR trials in patients with severe, uncontrolled asthma and comorbid nasal polyps.

Depemokimab/GSK3511294: GlaxoSmithKline

Depemokimab/GSK3511294, which GSK is developing to treat CRSwNP, is a humanized anti-interleukin (IL)-5 monoclonal antibody. As a new biological entity, it is engineered to ensure high affinity and long-acting suppression of IL-5 functions. IL-5 is cytokines responsible for the proliferation, activation, and survival of eosinophils, thus making them a proven treatment target for diseases with higher levels of eosinophils. Depemokimab, with an extended half-life and improved IL-5 affinity compared to other approved therapies, is being studied by GSK in Phase III to evaluate the efficacy and safety of depemokimab in participants with CRSwNP.

Get In-Depth Knowledge on Chronic Rhinosinusitis with Nasal Polyps Market Trends and Forecasts with DelveInsight @ Chronic Rhinosinusitis with Nasal Polyps Treatment Market

Chronic Rhinosinusitis with Nasal Polyps Therapies and Key Companies

NUCALA (mepolizumab): GlaxoSmithKline
TEZSPIRE (tezepelumab): AstraZeneca/Amgen
FASENRA (benralizumab): AstraZeneca
Tezepelumab: AstraZeneca/Amgen
CM310: Keymed Biosciences
GSK3511294 (depemokimab): GlaxoSmithKline
Omalizumab: Genentech, Inc
Xolair: Novartis
Verekitug (UPB-101): Upstream Bio Inc.
Dupilumab SAR231893: Regeneron Pharmaceuticals
GR1802 injection: Genrix (Shanghai) Biopharmaceutical
SHR-1905 Injection: Guangdong Hengrui Pharmaceutical
CM310: Keymed Biosciences Co.Ltd

Scope of the Chronic Rhinosinusitis with Nasal Polyps Market Report

Coverage- 7MM
Study Period- 2020-2034
Chronic Rhinosinusitis with Nasal Polyps Companies- AstraZeneca, Amgen, Keymed Biosciences, GlaxoSmithKline, Genentech, Inc, Novartis, Upstream Bio Inc., Regeneron Pharma, Genrix (Shanghai) Biopharmaceutical, Guangdong Hengrui Pharmaceutical, Keymed Biosciences Co.Ltd, and others
Chronic Rhinosinusitis with Nasal Polyps Therapies- NUCALA (mepolizumab), TEZSPIRE (tezepelumab), FASENRA (benralizumab), Tezepelumab, CM310, GSK3511294 (depemokimab), Omalizumab, Xolair, Verekitug (UPB-101), Dupilumab SAR231893, GR1802 injection, SHR-1905 Injection, CM310, and others
Chronic Rhinosinusitis with Nasal Polyps Market Dynamics: Chronic Rhinosinusitis with Nasal Polyps Market Drivers and Barriers
Chronic Rhinosinusitis with Nasal Polyps Unmet Needs, KOL’s views, Analyst’s views, Chronic Rhinosinusitis with Nasal Polyps Market Access and Reimbursement

Unlock Strategic Insights with DelveInsight’s Comprehensive Chronic Rhinosinusitis with Nasal Polyps Market Report @ Chronic Rhinosinusitis with Nasal Polyps Market Drivers and Barriers

Table of Content

1. Key Insights

2. Report Introduction

3. CRSwNP Market Overview at a Glance

4. Epidemiology And Market Forecast Methodology

5. Executive Summary of CRSwNP

6. Key Events

7. Disease Background and Overview

8. Epidemiology and Patient Population

9. Patient Journey

10. Marketed Therapies

11. Emerging Drugs

12. CRSwNP: Market Analysis

13. KOL Views

14. SWOT Analysis

15. Unmet Needs

16. Reimbursement and Market Access

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Rhinosinusitis with Nasal Polyps Market Size was highest in the US among the 7MM is ~USD 1,674 million in 2023, is expected to grow by 2034 at a CAGR of 10.8% | DelveInsight

Healthcare Interoperability Solutions Market worth $6.2 billion

“Browse in-depth TOC on “Healthcare Interoperability Solutions Market” 160 – Tables 37 – Figures 223 – Pages”

The healthcare interoperability solutions industry is expected to grow significantly in the near future due to the increasing demand for healthcare data exchange and integration.

Healthcare Interoperability Solutions Market in terms of revenue was estimated to be worth $3.4 billion in 2022 and is poised to reach $6.2 billion by 2027, growing at a CAGR of 12.9% from 2022 to 2027 according to a new report by MarketsandMarkets™. Growth in this market is driven by the increasing demand for efficient and cost-effictive healthcare delivery, government initiatives towards improving the healthcare interoperability. However, the lack of true interoperability among electric systems, financial burden and technical difficulties in building and operations are some factors restraining the growth of the healthcare interoperability solutions market to a certain extent during the forecast period. The base year considered for the study is 2021, while the forecast period is 2022 to 2027.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17705847

By type, the services segment accounted for the largest share of the healthcare interoperability solutions market in 2021.

On the basis of type: the services segment accounted for the largest share. The large share of this segment can be attributed to the advantages offered by the services such as installation, equipment updates or traditional licensing management are not required in case of services.

The healthcare providers segment is expected to witness the highest growth rate in the healthcare interoperability solutions market, by end user, during the forecast period

Based on end user: the healthcare providers segment is expected to register the highest CAGR during the forecast period. The growing geriatric population leading to the increasing hospital admissions is contributing to the growth of this segment.

North America dominated the healthcare interoperability solutions market in 2021

North America accounted for the largest share of the healthcare interoperability solutions market in 2021, followed by Europe and Asia Pacific. The rising demand for value-based healthcare, the need to reduce the increasing healthcare costs, and the implementation of favorable government initiatives & regulations in the region are the key factors responsible for the large share of North America in the healthcare interoperability solutions market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=17705847

Healthcare Interoperability Solutions Market Dynamics:

Drivers:

Increasing demand for efficient and cost-effective healthcare delivery
Government initiatives and regulations to enhance patient care and safety
Emergence of new medical technologies
Growing adoption of electronic health records

Restraints:

Lack of accurate interoperability solutions across healthcare supply chain
Lack of standards and protocols in IT businesses
Use of outdated legacy systems in hospitals and clinic chains

Opportunities:

Growing markets for healthcare interoperability solutions in developing countries
Advancements in software technology for real-time data exchange

Challenges:

Increasing complexity due to lack of consistent data
Shortage of skilled healthcare IT professionals
Patient data security and privacy concerns in healthcare industry

Key Market Players:

Some of the prominent players in this market are Cerner Corporation (US), Epic Systems Corporation (US), Infor, Inc. (US), Koninklijke Philips NV (Netherlands), InterSystems Corporation (US), Orion Health Group Limited (New Zealand), IBM Watson Health (US), Lyniate (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), and Medical Information Technology, Inc. (US), iNTERFACEWARE (Canada), OSP Labs (US), ViSolve, Inc. (US), Jitterbit (US), Virtusa Corp. (US), and Summit Healthcare Services, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=17705847

Healthcare Interoperability Solutions Market Advantages:

Improved patient outcomes: By providing access to data and records across different healthcare systems, healthcare interoperability solutions can help to improve overall patient outcomes by allowing physicians to better assess patient health and make more informed decisions.
Improved patient experience: By providing access to patient data across multiple healthcare systems, healthcare interoperability solutions can help to improve the overall patient experience. This can include better access to medical records, appointment scheduling, and access to care.
Reduced costs: By enabling healthcare providers to access patient data across different systems, healthcare interoperability solutions can help to reduce costs associated with manual data entry and other inefficient processes.
Improved data accuracy: By providing access to real-time data, healthcare interoperability solutions can help to improve data accuracy across multiple systems. This can help to reduce errors and improve overall patient care.
Improved analytics: By providing access to healthcare data across multiple systems, healthcare interoperability solutions can help to improve analytics and data-driven decision making. This can help to improve population health management, disease management, and patient care.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/healthcare-interoperability-solution-market-17705847.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Healthcare Interoperability Solutions Market worth $6.2 billion

Lucintel Forecasts Smart Port Market to Reach $11.2 billion by 2030

“Trends and Forecast for the Smart Port Market”

According to the recent study the smart port market is projected to reach an estimated $11.2 billion by 2030 from $2.7 billion in 2023, at a CAGR of 22.4% from 2024 to 2030. Growth in this market is primarily driven by increasing government initiatives for smart port, growing maritime transportation, and rising adoption of IoT technology.

A more than 150 – page report is developed to understand trends, opportunities and forecast in smart port market by element (terminal automation and cargo handling, port community system, smart safety and security, traffic management system, and smart port infrastructure), technology (process automation, internet of things (IoT), artificial intelligence, and blockchain), throughput capacity (extensively busy ports, moderately busy ports, and scarcely busy ports), port type (seaports and inland ports), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that process automation is expected to remain the largest technology segment over the forecast period due to increasing adoption of industry 4.0 technology by seaports to increase capacity.

Within this market, seaports will remain the larger port type segment as seaports have been equipped with powerful digital technology, smart sensors, and IoT, which helps in enhancing the operational productivity and also makes cargo management easier for the port authorities.

Download sample by clicking on smart port market

APAC will remain the largest segment over the forecast period because of increasing investment in ports for new technologies, like artificial intelligence and blockchain, and strong development in trade business in countries, like Singapore and Hong Kong.

ABB, IBM, Kaleris, Siemens, General Electric, Cisco, Trelleborg, ZPMC, Liebherr, Accentureare arebthe major suppliers in the smart port providers.

Download sample by clicking on

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1 972.636.5056

Explore Our Latest Publications

Memory Card Market

Microbial Fuel Cell Market

Trenbolone Enanthate Market

Uterine Fibroid Treatment Device Market

Anatomical Modelling Market

Ankylosing Spondylitis Treatment Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/smart-port-market.aspx

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts Smart Port Market to Reach $11.2 billion by 2030

Acne Vulgaris Therapeutics Market Size in the 7MM was ~USD 4,256 Million in 2023, is projected to grow by 2034, estimated DelveInsight

DelveInsight’s “Acne Vulgaris Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Acne Vulgaris, historical and forecasted epidemiology as well as the Acne Vulgaris therapeutics market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Explore the intricate details of the Acne Vulgaris Market: Uncover drug uptake, treatment dynamics, and epidemiological trends with our comprehensive Acne Vulgaris Market Forecast. Click here to stay ahead in healthcare innovation @ Acne Vulgaris Market Size

Key Takeaways from the Acne Vulgaris Market Report

In December 2024:- UCB Biopharma SRL- A Phase 3, Open-Label, Parallel Group, Multicenter, Extension Study Evaluating the Long-Term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa. The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (HS)
In December 2024:- Incyte Corporation- The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment within the originating parent Phase 3 studies (INCB 54707-301 [NCT05620823] or INCB 54707-302 [NCT05620836]).
As per the analysis, in Japan, the prevalence of acne vulgaris among the students was 58.6%, with the average onset at 13.3 years of age.
The evaluation of acne severity revealed that “mild acne” was the most common form across all subgroups, affecting 92% of adult females, 82% of adult males, 89% of teenage females, and 77% of teenage males, in Italy.
In a survey of employees in Germany, the overall prevalence of acne was found to be 4.2%. Other studies indicate that the prevalence of acne in adolescents aged 9 to 20 can reach up to 95%, without distinguishing between clinical and “physiologic” acne.
The leading Acne Vulgaris Companies such as Pelthos Therapeutics, Dermata Therapeutics, Botanix Pharmaceuticals, AOBiome LLC, BioPharmX, Timber Pharmaceuticals, and others
Promising Acne Vulgaris Therapies such as Clascoterone, DMT310, Winlevi (clascoterone) 1% & Duac gel, Erythromycin 4% topical gel formulation, ASC40, and others.

Stay ahead in the Acne Vulgaris Therapeutics Market with DelveInsight’s Strategic Report @ Acne Vulgaris Market Outlook

Acne Vulgaris Epidemiology Insights

Total Acne Vulgaris Prevalent Cases
Total Acne Vulgaris Diagnosed Prevalent Cases
Acne Vulgaris Gender-specific Diagnosed Prevalent Cases
Acne Vulgaris Severity-specific Diagnosed Prevalent Cases
Acne Vulgaris Treated Cases

Delve deep into the Acne Vulgaris Market Landscape: Analyze drug adoption, treatment paradigms, and epidemiological shifts in our detailed Acne Vulgaris Market Forecast. Click here to shape the future @ Acne Vulgaris Prevalence

Acne Vulgaris Marketed Drugs

AKLIEF: Galderma Labs

AKLIEF (trifarotene) Cream, 0.005%, is indicated for the topical treatment of acne. It selectively targets retinoic acid receptor (RAR) gamma, the most common RAR found in the skin, making it the first topical retinoid to do so. Trifarotene is the first new retinoid molecule to receive US FDA approval for acne treatment in over 20 years. AKLIEF Cream is specifically studied and proven to treat both facial (forehead, cheeks, nose, and chin) and truncal (chest, shoulders, and back) acne, providing healthcare professionals and acne patients with an additional treatment option.

ARAZLO: Ortho Dermatologics/Bausch Health

ARAZLO (tazarotene) Lotion, 0.045%, is a prescription medication used topically to treat acne in individuals aged 9 years and older. It effectively addresses various acne symptoms, including blackheads, whiteheads, and other types of pimples. Notably, ARAZLO is the first tazarotene acne treatment available in lotion form, offering strong efficacy coupled with favorable tolerability.

CABTREO: Ortho Dermatologics/Bausch Health

CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1% is a prescription medication specifically designed for topical use on the skin to treat acne vulgaris in adults and children aged 12 years and older. It is the first and only FDA-approved fixed-dose, triple-combination topical treatment for acne, combining clindamycin phosphate, adapalene, and benzoyl peroxide to effectively address acne symptoms.

Acne Vulgaris Emerging Drugs

BPX-01: Timber Pharmaceuticals/BioPharmX

BPX-01 (topical minocycline, 2%) is being developed for the treatment of moderate-to-severe acne. In a Phase 2b study, treatment with BPX-01 showed a statistically significant reduction in the number of acne lesions, with no serious adverse events related to study treatment. BPX-01 is a hydrophilic topical gel with fully solubilized minocycline capable of penetrating the skin to deliver the antibiotic to where acne develops in the pilosebaceous unit. Currently, the drug is in Phase II of clinical development for the treatment of acne.

KX-826: Kintor Pharma

KX-826 is being developed by Kintor Pharmaceuticals, for Acne vulgaris. This agent targets mild to moderate patients and is being developed in topical formulation. The company is looking forward to the next step of filing IND to initiate the clinical development of the drug.

BTX 1503: Botanix Pharmaceuticals

Botanix Pharmaceuticals is advancing BTX 1503, a novel topical treatment designed for moderate to severe acne. This formulation harnesses synthetic cannabidiol as the active drug component, in conjunction with Botanix’s proprietary Permetrex drug delivery technology. Notably, the company has released Phase II results and is now preparing for Phase III clinical trials for the treatment of acne.

Get In-Depth Knowledge on Acne Vulgaris Market Trends and Forecasts with DelveInsight @ Acne Vulgaris Treatment Market

Acne Vulgaris Drugs Market

According to DelveInsight’s estimates, the Acne Vulgaris market size in the 7MM is expected to show positive growth, during the forecast period (2024–2034), mainly attributed to the increasing prevalence of acne vulgaris, growing awareness and diagnoses, and the new product launches. The expected increase in treated cases of acne vulgaris in the US is driven by factors such as improved awareness, advancements in treatment options, changing lifestyles, and evolving societal attitudes towards skincare and self-care. These factors collectively contribute to a greater demand for acne treatment and management services. Furthermore these cases are subjected to change during the forecast period (2024-2034).

Acne Vulgaris Treatment Landscape

Acne treatment depends on the individual’s age and sex, the extent and severity of the acne, the period since it has been present, and response to previous treatments. Treatment for mild acne includes topical anti-acne preparations, lasers and lights. Treatment for moderate acne includes antibiotics such as tetracyclines and/or antiandrogens such as birth controlpills. Treatment for severe acne may require a course of oral isotretinoin. Azelaic acid is a naturally occurring acid produced by yeast. It has antibacterial properties. A 20% azelaic acid cream or gel seems to be as effective as many conventional acne treatments when used twice a day.

Acne Vulgaris Market Insights

Several treatments are available for acne vulgaris, there is a need for more effective long-term maintenance therapies to prevent acne recurrence and minimize the risk of scarring. Some individuals with acne vulgaris may not respond adequately to existing treatments, including antibiotics, topical retinoids, and hormonal therapies. There is a need for alternative treatment options for these resistant cases. Many acne treatments, particularly oral medications like isotretinoin, can have significant side effects. There is a need for therapies that effectively treat acne while minimizing adverse effects, especially in adolescents and young adults. Acne vulgaris is a heterogeneous condition, and treatment efficacy can vary greatly among individuals. There is a need for personalized treatment approaches that take into account factors such as acne severity, skin type, hormonal status, and potential comorbidities.

Unlock insights into the Acne Vulgaris Market: discover drug uptake patterns, treatment landscapes, and epidemiological insights with our exclusive Acne Vulgaris Market Forecast. Click here @ Acne Vulgaris Market Drivers and Barriers

Scope of the Acne Vulgaris Market Report

Coverage- 7MM
Study Period- 2020-2034
Acne Vulgaris Companies- Pelthos Therapeutics, Dermata Therapeutics, Botanix Pharmaceuticals, AOBiome LLC, BioPharmX, Timber Pharmaceuticals and others
Acne Vulgaris Therapies- Clascoterone, DMT310, Winlevi (clascoterone) 1% & Duac gel, Erythromycin 4% topical gel formulation, ASC40, and others.
Acne Vulgaris Market Dynamics: Acne Vulgaris Market drivers and Exocrine Pancreatic Insufficiency Market Barriers
Acne Vulgaris Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Acne Vulgaris Unmet Needs, KOL’s views, Analyst’s views, Acne Vulgaris Market Access and Reimbursement

Table of Content

1 Key Insights

2 Report Introduction

3 Acne Vulgaris Market Overview at a Glance

4 Epidemiology and Market Methodology

5 Executive Summary

6 Acne Vulgaris Key Events

7 Disease Background and Overview: Acne Vulgaris

8 Epidemiology and Patient Population

9 Patient Journey

10 Marketed Therapies

11 Emerging Therapies

12 Acne Vulgaris: Seven Major Market Analysis

13 Key Opinion Leaders’ Views

14 Unmet Needs

15 SWOT Analysis

16 Acne Vulgaris Market Access and Reimbursement

17 Appendix

18 DelveInsight Capabilities

19 Disclaimer

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Acne Vulgaris Therapeutics Market Size in the 7MM was ~USD 4,256 Million in 2023, is projected to grow by 2034, estimated DelveInsight

Lucintel Forecasts Prepreg Market to Reach $7.0 Billion by 2030

“Trends and Forecast for the Prepreg Market”

According to the recent study the prepreg market is projected to reach an estimated $7.0 billion by 2030 from $4.6 billion in 2023, at a CAGR of 6.0% from 2023 to 2030. Growth in this market is primarily driven by growing demand for high performance composite materials and the replacement of metals with composites in different end use industries.

Browse 138 figures / charts and 96 tables in this 240 -page report to understand trends, opportunities and forecast in prepreg market by end use (commercial aerospace, military/defense, general aviation, space/satellite, sporting goods, marine, wind energy, automotive, civil engineering, and others), weave type (fabric prepreg, unidirectional prepreg), manufacturing technology (hot melt and solvent dip), prepreg type (thermoset prepreg and thermoplastic prepreg), reinforcement type (carbon fiber, glass fiber, and aramid fiber), resin type (epoxy prepreg, BMI prepreg, phenolic prepreg, cynate ester prepreg, and thermoplastics prepreg), and region (North America, Europe, Asia Pacific, and Rest of the World).

Lucintel forecasts that commercial aerospace will remain the largest end use by value and volume and it is also expected to witness highest growth over the forecast period due to increasing demand for lightweight materials in new aircraft programs, such as Boeing 787 and Airbus A350.

Thermoset prepreg will remain the largest segment over the forecast period due to its wide usage in aerospace/defense, wind energy and automotive end use. Thermoplastic prepreg is expected to witness the hightest growth over the forecast period.

Download sample by clicking on prepreg market

North America is expected to remain the largest region and witness the highest growth over the forecast period due to increasing residential construction and government regulations for energy efficiency.

Hexcel Corporation, Solvay, Gurit, Toray Industries Inc., SGL Carbon, Mitsubishi Chemical Corporation, Teijin Limited are the major suppliers in the prepreg providers.

About Lucintel

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1 972.636.5056

Explore Our Latest Publications

Adhesives and Sealants Market

Fiberglass Insulation Market

Flame Retardant Plastics Market Trends

Food Processing Market

Fuel Additives Market

Green Coatings Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 9726365056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/prepreg-market.aspx

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts Prepreg Market to Reach $7.0 Billion by 2030

Lucintel Forecasts Thermoplastic Unidirectional Tape Market to Reach $272.0 million by 2030

“Trends and Forecast for the Thermoplastic Unidirectional Tape Market”

According to the recent study the thermoplastic unidirectional tape market is projected to reach an estimated $272.0 million by 2030 from $167.2 million in 2023, at a CAGR of 7.0% from 2023 to 2030. Growth in this market is primarily driven by increasing use of thermoplastic composites because it offers recyclability and processing benefits, such as ability to remold, shorter cycle time, and no emission of volatile matter.

Browse 139 figures / charts and 97 tables in this 171 -page report to understand trends, opportunities and forecast in thermoplastic unidirectional tape market by end use (aerospace and defense, transportation, sporting goods, industrial and others), reinforcement type (carbon fiber, glass fiber and others), manufacturing process (thermoforming, injection molding, prepreg layup, ATL/AFP, and others), resin type (polypropylene, polymide, polyphenylene sulfide, polyether ether ketone), and region (North America, Europe, and Asia Pacific & ROW).

Lucintel forecasts transportation will remain the largest end use segment over the forecast period due to the increasing demand for lightweight materials to achieve higher fuel efficiency and reusable and recyclable materials for environmental benefits. Industrial is expected to witness the highest growth during the forecast period.

Glass fiber type thermoplastic unidirectional tape will remain the largest segment and carbon fiber is likely to witness the highest growth in the forecast period supported by increasing usage of lightweight materials in aircraft components.

Download sample by clicking on thermoplastic unidirectional tape market

North America is expected to remain the largest market by value and volume over the forecast period because of rising penetration of thermoplastic unidirectional tape in major end usees. It is also expected to witness highest growth over the forecast period.

Cytec Solvay Group, QIVI Technology, Polystrand (polyone), Tencate Advance Composites, Toho Tenax, SABIC, and SGL Group are the major supplier in the thermoplastic unidirectional tape market.

About Lucintel

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Hydrogen Compressor Market

Hydrogen Hub Market

Hydrogen Flouride Gas Detection Market

Arthroscopic Visualization Instrument Market

Assisted Living Technology Market

Cancer Cachexia Market